Compound concentration required to reduce the cell proliferation of human acute B-lymphoblastic leukemia CCRF-SB cells by 50%, using MTT method

Basic Information

ID: ALA651474

Type: Functional

Description: Compound concentration required to reduce the cell proliferation of human acute B-lymphoblastic leukemia CCRF-SB cells by 50%, using MTT method

Format: BAO_0000219

Organism: Homo sapiens

Cell type: CCRF-SB

Target: CCRF-SB(ALA614542)

Document: ALA1135654

Compound concentration required to reduce the cell proliferation of human acute B-lymphoblastic leukemia CCRF-SB cells by 50%, using MTT method: 1

Associated Items: Associated Bioactivities Associated Compounds

Activity Charts

Bioactivity

Activity Types for Assay ALA651474

IC50

Total(1)

Parent Molecular Weight	ALogP	Polar Surface Area
212.21	1.88	1.88

Parent Molecular Weight

ALogP

Polar Surface Area

212.21

1.88

Compound concentration required to reduce the cell proliferation of human acute B-lymphoblastic leukemia CCRF-SB cells by 50%, using MTT method

Basic Information

Activity Charts

Compound Summary